EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of HLA ‐haploidentical donors with post‐transplant cyclophosphamide versus HLA ‐matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia

Makoto Moriguchi iD, Hirohisa Nakamae iD, Mitsutaka Nishimoto iD, Junichi Sugita, Masamitsu Yanada iD, Tomomi Toubai iD, Yuta Hasegawa, Masayuki Hino, Tetsuya Nishida, Naoki Kurita, Masashi Sawa, Takahiro Fukuda und 12 weitere

British Journal of Haematology · 2024-12 · 205 (6) · 2376-2386

DOI: 10.1111/bjh.19825 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift British Journal of Haematology, online erschienen am 22.10.2024. Verfasst von Makoto Moriguchi und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Cyclophosphamide, Leukemia, Myeloid, Acute, Peripheral Blood Stem Cell Transplantation, Unrelated Donors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HLA‐haploidentical haematopoietic cell transplantation with post‐transplant cyclophosphamide (PTCy‐haplo) is emerging as an effective alternative due to donor availability and safety. We conducted a nationwide retrospective study comparing the outcomes of PTCy‐haplo with both anti‐thymocyte globulin (ATG)‐free and ATG‐administered matched unrelated donors (MUD) transplantation, using peripheral blood stem cells as the first transplantation for acute myeloid leukaemia (AML). Our study showed a lower and slower haematopoietic recovery and a higher incidence of infection‐related deaths after PTCy‐haplo than after MUD transplantation. In addition, we revealed an increased risk of acute and chronic graft‐versus‐host disease (GVHD) in ATG‐free MUD transplantation in comparison to PTCy‐haplo. For grades III–IV acute GVHD, the hazard ratio (HR) was 2.71 (95% CI, 1.46–5.01), and for extensive chronic GVHD, the HR was 3.11 (95% CI, 2.07–4.68). There was no significant difference regarding overall survival amongst the groups. In addition, GVHD‐free relapse‐free survival (GRFS) was lower in ATG‐free MUD transplantation than in PTCy‐haplo (HR, 1.46; 95% CI, 1.17–1.82). Notably, ATG‐administered MUD transplantation showed no significant difference in GRFS from PTCy‐haplo, negating the advantage of PTCy. Our results suggest that PTCy‐haplo could be viable for AML patients without an HLA‐matched related donor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamideLeukemia, Myeloid, AcutePeripheral Blood Stem Cell TransplantationUnrelated DonorsGraft vs Host DiseaseHumansFemaleMaleMiddle AgedAdultRetrospective StudiesAdolescentAgedAntilymphocyte SerumYoung AdultHLA Antigens

Stichwörter der Autor:innen

acute myeloid leukaemiahaploidentical donormatched unrelated donorperipheral blood stem cell transplantationpost‐transplant cyclophosphamide

Substanzen

CyclophosphamideAntilymphocyte SerumHLA Antigens

Autor:innen und Institutionen

  • Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Department of Hematology and Oncology, Nagoya City University East Medical Center, Nagoya, Japan.
  • Department of Hematology and Cell Therapy, Yamagata University Hospital, Yamagata, Japan.
  • Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.
  • Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.

ORCID-Profile: Makoto Moriguchi, Hirohisa Nakamae, Mitsutaka Nishimoto, Masamitsu Yanada, Tomomi Toubai, Shuichi Ota, Ken-Ichi Matsuoka, Yoshinobu Kanda, Yoshiko Atsuta, Hideki Nakasone, Takaaki Konuma

Zitieren

APA

Moriguchi, M., Nakamae, H., Nishimoto, M., Sugita, J., Yanada, M., Toubai, T., Hasegawa, Y., Hino, M., Nishida, T., Kurita, N., Sawa, M., Fukuda, T., Jinguji, A., Ota, S., Matsuoka, K. I., Eto, T., Hiramoto, N., Ando, T., Kawamura, K., …, & Konuma, T. (2024). Comparison of HLA ‐haploidentical donors with post‐transplant cyclophosphamide versus HLA ‐matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia. British Journal of Haematology, 205(6), 2376-2386. https://doi.org/10.1111/bjh.19825

Vancouver

Moriguchi M, Nakamae H, Nishimoto M, Sugita J, Yanada M, Toubai T, et al. Comparison of HLA ‐haploidentical donors with post‐transplant cyclophosphamide versus HLA ‐matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia. British Journal of Haematology. 2024;205(6):2376-2386. doi:10.1111/bjh.19825

BibTeX
@article{Moriguchi2024,
  author = {Moriguchi, Makoto and Nakamae, Hirohisa and Nishimoto, Mitsutaka and Sugita, Junichi and Yanada, Masamitsu and Toubai, Tomomi and Hasegawa, Yuta and Hino, Masayuki and Nishida, Tetsuya and Kurita, Naoki and Sawa, Masashi and Fukuda, Takahiro and Jinguji, Atsushi and Ota, Shuichi and Matsuoka, Ken-Ichi and Eto, Tetsuya and Hiramoto, Nobuhiro and Ando, Toshihiko and Kawamura, Koji and Kanda, Yoshinobu and Atsuta, Yoshiko and Ohbiki, Marie and Nakasone, Hideki and Konuma, Takaaki},
  title = {Comparison of HLA ‐haploidentical donors with post‐transplant cyclophosphamide versus HLA ‐matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia},
  journal = {British Journal of Haematology},
  year = {2024},
  volume = {205},
  number = {6},
  pages = {2376--2386},
  doi = {10.1111/bjh.19825}
}
Kostenlos starten →